Cmarx Competitors

Teladoc Health is the global leader in virtual care, delivering and orchestrating care across patients, care providers, platforms and partners – transforming virtual care into a catalyst for how better health happens. Our comprehensive care offerings span primary care, mental health, chronic condition management and more, all integrated on a single platform. We partner with employers, health plans, hospitals, health systems and other providers to fuel clinical excellence and apply the power of technology to help people live their healthiest lives. Follow us for industry insights, virtual care trends, client success stories and expert perspectives shaping the future of healthcare. For more information, please visit www.teladochealth.com or follow @TeladocHealth on X.

Reliance HMO is a technology driven health insurance company that has integrated technology into every sphere of health-care management. The company started in 2017 with a vision of using technology to make insurance accessible and easy to use. Reliance pro-actively makes use of artificial intelligence and data science for personalized health-care, preventative health-care that reduces hospital admissions and optimizing access to health care. Enrolees enjoy a curated network of top rated hospitals, a dedicated medical support team that includes doctors on call and a 24/7 access to doctor’s consultation online. Reliance, is the first insurance company in Africa to make telemedicine services completely free for all enrolees. Reliance members can easily access care online, view their health history and manage account information through an intuitive web and mobile app experience. For more information, visit http://www.RelianceHMO.com | | Contact hello@reliancehmo.com I 070073542623 for all enquires.

Biovac was founded in 2003 to revive and restore South Africa’s vaccine manufacturing capabilities. We are an African based manufacturer contributing towards filling the gap that exists in the lack of African vaccine manufacturing capability. We recognise that we’ll only achieve this if we match scientific innovation through local biotechnology skills with the most advanced manufacturing technology and global partnerships. We work closely with local academic institutions, global pharmaceutical companies, the public sector as well as private sector. Some of our achievements are described below: We manufacture highly advanced vaccines on behalf of leading international biopharmaceutical companies. Biovac is licensed to manufacture a fully liquid hexavalent vaccine from Sanofi that targets and protects against six childhood diseases. In 2021, we envisage to start the manufacture of a multivalent pneumococcal conjugate vaccine from Pfizer. We supply over 15-million doses of vaccines a year in South Africa and neighbouring countries under strict cold chain conditions. We have built inhouse product development capability and technologies and have successfully out-licensed one of our technologies to international manufacturers. We are working to establish new safeguards against pathogens like group B streptococcus bacteria, a rising cause of sepsis and meningitis in newborns. To do this vital work, we rely on sophisticated technology and, above all, the skills and dedication of more than 350 highly trained team members. Along with our partners, we’ve invested over R800 million in infrastructure and skills development at our manufacturing facilities in Cape Town. These investments are resulting in estimated benefits of more than R500-million a year to the national economy.